Report      Database

    Pediatric Vaccines Market to be more than USD 40 Billion Globally by 2022
    19 Jul, 2017


    Over a period of time, Pediatric Vaccines Market has been mounting at a great pace. Pediatric Vaccines Market worldwide is estimated to be more than US$ 40 Billion by the year 2022. Pediatric Vaccines Market is more enhanced by combination vaccines and Boosters vaccines as it is expected to show good growth in coming years because of the higher margins. 

    Pediatric Vaccine is given to the children in the age which are from 0-18 years. Vaccines are given to children to fight from diseases, infections, seasonal variations and from unhygienic conditions. Vaccination varies from disease to disease; vaccines are given to children at regular intervals. The cases like of Polio, Haemophilus Influenza Type B(HIB) and MMR have shown continuously fallen down from the year 2001 to 2011. The primary reason for this is that India is on a verge of Polio free country as not a single case of Polio reported in recent years.


    500 Million Infants to get Immunization by 2022
    Immunization is vital component for modern day vaccine and is of paramount importance for worldwide health. Certain standard of immunizations program planned in order to have desired time interval between vaccines doses.
    Over 500 million infants get immunization by the year 2022 owing to increasing concern against Vaccine preventable diseases and rising awareness.
    Overall Immunization processes for children have many vaccines in common but, it depends upon region to region. Mostly developed countries follow similar primary immunization schedule, as opposed to developing countries. Another reflection relating to International immunization is the use of Travel Vaccines. This is because as the number of International travelers including children continue to rise, as children are more at risk of microbial infection than adults. Hepatitis, Polio and Meningococcal are often prioritized over precise Travel Vaccines, as these diseases are still prevailing in many developing countries. Typhoid Fever, Yellow Fever, Encephalitis etc are the next concern, as these diseases are common in developing countries irrespective of Travel Vaccine.
    Some of the Pediatric Vaccine Market players are GlaxoSmithKline, Merck & Co. Inc, Pfizer Inc, Sanofi, Panacea BioTech, Zydua Cadila, Emergent BioSolution Inc, Serum Institute of India Pvt Ltd, Bharat Biotech and Indian Immunologicals Ltd. 


    The Report Studies the Pediatric Vaccines Market on the basis of:
    Vaccines Market (2011 – 2022) 
    1.    Influenza
    2.    MMR (Measles, Mumps, and Rubella)
    3.    Pneumococcal
    4.    Meningococcal
    5.    Hepatitis
    6.    DTap (Diphtheria, Tetanus, Pertussis)
    7.    Haemophilus influenzae type B
    8.    Polio
    9.    Rotavirus
    10.    Varicella
    11.    Combination Vaccine 

    Key Players (2011 – 2022)

    1. GlaxoSmithKline, plc     
    2. Merck & Co. 
    3. Sanofi Pasteur’s 
    4. Pfizer, Inc.’s 


    About Us

    Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.


    Contact Us

    Renub Research

    Phone: +1-678-302-0700



    Follow us on LinkedIn:



    Related Products